Wanchai, Guangdong, China Zuellig Pharma China appeared to be the Corporate Investor, which was created in 1922. The main department of described Corporate Investor is located in the Wanchai. The company was established in Asia in China.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Zuellig Pharma China, startups are often financed by Pegasus Tech Ventures, TA Ventures, StartX (Stanford-StartX Fund). The meaningful sponsors for the fund in investment in the same round are Susquehanna International Group (SIG), Sojitz, Silicon Valley Bank.
Among the most popular portfolio startups of the fund, we may highlight Sensely. We can highlight the next thriving fund investment areas, such as InsurTech, Mobile. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
| Fund Name | Location |
| Bergen Asset Management | New York, New York, United States |
| Chiefswood Holdings Limited | - |
| China Life Insurance | Beijing, Beijing, China |
| China Trends Holdings | China, Hong Kong, Hong Kong Island |
| FINUP | Beijing, Beijing, China |
| Guotai Junan International | China, Hong Kong, Hong Kong Island |
| JZ International Ltd. | England, London, United Kingdom |
| Leadenhall Capital Partners | England, London, United Kingdom |
| California, Sunnyvale, United States | |
| Lola Tech Ltd | England, London, United Kingdom |
| Maker Institute CAS | China, Guangdong, Tianjin |
| Olymp Capital | Luxembourg, Luxembourg |
| Radar Endeavour Group | - |
| Sawaf Ventures | California, Los Gatos, United States |
| Shenzhen Weixi VC | China, Henan, Zhengzhou |
| Shenzhen Xindixin Investment | China, Guangdong, Shenzhen |
| Supply Chain Ventures | Boston, Massachusetts, United States |
| TPG Capital Asia | China, Hong Kong, Hong Kong Island |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 